Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The first ever Orthopaedic Surgical Trials Day was held at the Royal College of Surgeons (RCS) this March. The objective of the day was to bring together the orthopaedic surgical research community to present current trials, intended projects and discuss issues that affect surgical trial research in this area.

The first ever Orthopaedic Surgical Trials Day was held at the Royal College of Surgeons (RCS) this March. The objective of the day was to bring together the orthopaedic surgical research community to present current trials, intended projects and discuss issues that affect surgical trial research in this area.

The workshop was  attended by both experienced and novice clinical researchers, surgeons, research nurses and the odd Channel 4 newsreader! Jon Snow gave a talk about the role media can play in promoting clinical research.

NDORMS were well represented at the event, with Head of department Professor Andrew Carr presenting on “Challenges with surgical trials” and Professor David Beard speaking about the 'Can Shoulder Arthroscopy Work?' study (CSAW); Professor Beard also highlighted other studies from the NDORMS Surgical Intervention Trials Unit (SITU) portfolio. Naomi Merritt and Cushla Cooper, from the CSAW study hosted a breakout session in collaboration with colleagues from the University of Bristol; their session focused on the perils of recruiting patients to studies and they presented work from the Qualitative Recruitment Investigation that was included in the CSAW study.

The event showed how far we have come in the world of surgical research and it was very rewarding for the SITU team to see how the increasing portfolio of orthopaedic and plastics trials in the its portfolio (UKUFF, TOPKAT, CSAW, NINJA) has helped shape current orthopaedic surgical trials research. The day also provided an excellent opportunity for the Oxford group to share their knowledge and experience with the wider orthopaedic community and the team are very much looking forward to sponsoring more of these events and, along with a strong partnership with the British Orthopaedic Association unit at York, help move orthopaedic research into the future.

The RCS day was supplemented by a Trauma and Orthopaedics trials day and Trauma Society special interest day hosted by Professor Matt Costa in Warwick. Again, Oxford had good representation with David Beard speaking on behalf of SITU.

The day was sponsored jointly by the RCS, the Oxford Surgical Intervention Trials Unit at NDORMS and the British Orthopaedic Association Orthopaedic Surgery Research Centre (York Trials Unit).

If you have any comments on the day or would like to find out more, please contact Cushla Cooper, SITU Portfolio Manager (Orthopaedics & Plastics).

Similar stories

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.